000 | 01535 a2200409 4500 | ||
---|---|---|---|
005 | 20250514062946.0 | ||
264 | 0 | _c20031120 | |
008 | 200311s 0 0 eng d | ||
022 | _a0143-4004 | ||
024 | 7 |
_a10.1053/plac.2002.0917 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMartel, F | |
245 | 0 | 0 |
_aUptake of 1-methyl-4-phenylpyridinium (MPP+) by the JAR human placental choriocarcinoma cell line: comparison with 5-hydroxytryptamine. _h[electronic resource] |
260 |
_bPlacenta _cApr 2003 |
||
300 |
_a361-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a1-Methyl-4-phenylpyridinium _xmetabolism |
650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aChoriocarcinoma _xmetabolism |
650 | 0 | 4 |
_aDesipramine _xpharmacology |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluoxetine _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
650 | 0 | 4 | _aMembrane Transport Proteins |
650 | 0 | 4 | _aNerve Tissue Proteins |
650 | 0 | 4 |
_aPlacenta _xdrug effects |
650 | 0 | 4 |
_aQuinolinium Compounds _xpharmacology |
650 | 0 | 4 |
_aSerotonin _xmetabolism |
650 | 0 | 4 | _aSerotonin Plasma Membrane Transport Proteins |
650 | 0 | 4 |
_aUterine Neoplasms _xmetabolism |
700 | 1 | _aKeating, E | |
773 | 0 |
_tPlacenta _gvol. 24 _gno. 4 _gp. 361-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1053/plac.2002.0917 _zAvailable from publisher's website |
999 |
_c12451166 _d12451166 |